ClinicalTrials.gg
Drug

Lidocaine clinical trials

Also written Xylocaine, Lidoderm, ALGRX 3268 and Akten.

Includes 47 studies of Lidoderm.

studies test it
1,082
open now
172
in phase 3
159
first study started
1997

Counted the way a researcher would: Lidocaine with its salts, dosage forms, brands and biosimilars. Looking for a trial to join? Including related medicines shows more you could take part in.

This browser remembers your choice.

How each study uses Lidocaine is sorted by a rule, right about nine times in ten. Readers can ask us to read every study one by one.Ask us to read each study

Get an email when these change. Save the Lidocaine studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.

Watch these studies
See an example email

Example · made-up studies

Breast cancer · Recruiting: 2 came in, 3 changed

What changed in your saved searches, Oct 31 – Nov 6:

A study of drug A after surgery for early breast cancer

Came in · now Recruiting

Drug B with hormone therapy in advanced breast cancer

Changed

· Sites: 4 added, including Seoul and Busan

· Enrollment: 300 → 450 participants

Exercise during chemotherapy

Now Active, not recruiting

One email a week for all your saved searches. Stop any time.

Approvals

The first approval found in each region, with its record

United States
19 Nov 1948 · XYLOCAINE · NDA 006488 (FDA, Drugs@FDA)
European Union
15 Nov 2013 · Fortacin · EMEA/H/C/002693 (EMA; in a combination)

From FDA's Drugs@FDA and Purple Book (through openFDA) and the European Medicines Agency, files of Sept 2026 and 27 Oct 2026. National approvals in Europe and other countries are not included. How this is worked out

How studies write it

Studies that test it under each name

Name

Lidocaine
416
Lidocaine Hydrochloride
73
Lidocaine IV
40
Lidocaine Infusion
21
Lidocaine 2% Injectable Solution
18

Brand

Lidoderm
3
Akten
2
Zingo
1

Development codes

ALGRX 3268
3
ORE001
1

Other names

Xylocaine
80
Lignocaine
33
2-(Diethylamino)-2',6'-acetoxylidide
1

In one entry with another drug

Given together, or one or the other

EMLA
11
Lidocaine epinephrine
5
2% Lidocaine with 1:100,000 epinephrine
4
Lidocaine/tetracaine patch
4
lidocaine with epinephrine
3
methylprednisolone acetate and lidocaine
3
Lidocaine and ketamine
2
Lidocaine epinephrine buffered with sodium bicarbonate
2

Studies by the year they started

1,075 studies that test it; most in 2024 (78); 4 more planned to start later

Studies that test Lidocaine, by start year
YearStudies
19971
20026
20037
200411
200516
20067
200723
200835
200924
201040
201147
201227
201338
201445
201549
201665
201749
201866
201967
202059
202160
202251
202372
202478
202570
202662

By phase

A phase 1/2 study counts in both.

Early Phase 1
29
Phase 1
63
Phase 2
152
Phase 3
159
Phase 4
310
No phase
427

What it is tested for

Each study’s main condition, where its own words name it, so a study counts once.

Who runs them

Industry 61 · Other 1,021

Assiut University (32) · Cairo University (26) · Ain Shams University (21) · Endo Pharmaceuticals (11) · Tanta University (10) · Mayo Clinic (10) · Copka Sonpashan (10) · Duke University (10)

Often tested with

Tested in the same studies.

Dexmedetomidine (59) · Ketamine (41) · Bupivacaine (38) · Epinephrine (31) · Magnesium Sulfate (19) · Fentanyl (18) · Ropivacaine (17) · Propofol (16)

Related medicines

As reviewed, each with the page that says it.

Coming up

From the study records. Dates are the sponsors’ own estimates and often move.

Tested against it · 3 phase 3 studies under way

Lidocaine is the comparator. A study of two new drugs counts under both.

  • 1Diphenhydramine · Florida Atlantic University · next primary completion Jun 2027
  • 1Ketamine · State University of New York at Buffalo
  • 1Fentanyl · State University of New York at Buffalo
Reaching primary completion within a year · 53, 5 in phase 3

Studies that test Lidocaine, phase 3 first.

Studies

Open first, then newest update. How each study uses Lidocaine is read from its arms, and is right about nine times in ten. Ask us to read each study. These are the studies that list it as an intervention; a search of ClinicalTrials.gov also finds studies that mention it only in a description, such as earlier treatment.

Testing it · 1,082

See all 1,082 studies that test Lidocaine →

Given beside what is tested · 116 — Lidocaine is usual care or a partner of the new treatment

Showing 20 of 116.

As the comparator · 129 — what is tested is compared with Lidocaine

Showing 20 of 129.

What changed recently

From the registry's own updates since Oct 16, 2026.

Codes

What other systems call Lidocaine · ClinicalTrials.gg INT007735

  • MeSH (NLM) D008012LidocaineConfirmed ClinicalTrials.gov, NLM, Wikidata
  • UNII (FDA) 98PI200987LIDOCAINEConfirmed FDA, NLM, Wikidata
  • RxNorm 6387Confirmed FDA, Wikidata
  • Wikidata Q216935lidocaineConfirmed FDA, NLM, Wikidata
  • NCI Thesaurus C614LidocaineOne source FDA
  • DrugBank DB00281One source Wikidata

Also registered as lidocaine hydrochloride (UNII V13007Z41A · RxNorm 142440).

“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.